Focus Stocks
Priceline.com near Resistance
Published on Thursday, 09 February 2012 07:56 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of Priceline.com Incorporated (NASDAQ:PCLN) are trading very close to calculated resistance at $549.00 with the current price action closing at just $538.37 placing the stock near levels that make it difficult to buy.
Priceline.com Incorporated (NASDAQ:PCLN) operates as an online travel company that enables consumers to save money on a variety of products and services. The Company allows customers to name their own price on products or services and communicates that demand directly to participating sellers or to their private databases. Participants include domestic and international airlines, and hotel chains.
Priceline's current stock range is defined by current calculated support defined at $438.76 and by the resistance level at $549.00, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Priceline.com , as the stock is well above support, however, as the stock pulls back towards $438.76 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $549.00 then traders will get an opportunity to enter Priceline.com stock by establishing a position as the stock moves to a higher range.
Related Articles
- Priceline.com Higher With High Volume
- Bulls and Bears on the Trenches of Priceline.com
- Sellers in Control - Priceline.com
- TradersHuddle Scanner - High Volume For Priceline.com
- TradersHuddle Scanner - High Volume For Priceline.com
- TradersHuddle Scanner - High Volume For Priceline.com
- Earnings Review: DIS, FOSL, PCLN, MNST
- Priceline.com - Above Average Volume Detected
- Dow snapped 6-Day Losing Streak
- Priceline broke below 50day Moving Average on Disappointing Guidance
Related Partner Headlines
- Priceline.com Inc. (PCLN): Today's Featured Leisure Loser - TheStreet.com
- Momentum Stocks Update (PCLN, SBUX, CMG) - Benzinga
- 5 Services Stocks With The Highest EPS Estimates For The Next Quarter - Benzinga
- Priceline.com Inc. (PCLN): Today's Featured Leisure Loser - TheStreet.com
- Priceline.com Down 4% on Lower Than Expected Guidance - Benzinga
- Priceline Lower on Mixed Earnings, Guidance - TheStreet.com
- Earnings Preview: StockTwits Users Weigh in on Priceline.com Ahead of Earnings - Benzinga
- Bottom-Callers Are Active - TheStreet.com
- Priceline.com Inc. (PCLN): Today's Featured Leisure Loser - TheStreet.com
- Priceline.com Inc. (PCLN): Today's Featured Leisure Loser - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









